Boswellia Extract Powder

Boswellia extract powder represents the pinnacle of naturally derived, clinically-validated support for joint comfort and a healthy inflammatory response. Sourced from the sacred resin of the Boswellia serrata tree (Indian Frankincense), our scientifically standardized extract concentrates the most potent bioactive constituents. JoyWin Natural supplies premium-grade Boswellia Extract, rigorously standardized to contain a minimum of 65% 3-O-Acetyl-11-keto-β-Boswellic Acid (AKBA) and 90% total Boswellic Acids-the highest commercial potency available for superior efficacy.

Unlike generic extracts, our formulation specifically targets AKBA, the most pharmacologically active boswellic acid, renowned for its selective, non-redox inhibition of the 5-lipoxygenase (5-LOX) enzyme. This specific enzymatic action modulates the leukotriene pathway without affecting the protective cyclooxygenase (COX) pathway, offering a targeted, well-tolerated approach to managing inflammatory cascades. For B2B clients in the nutraceutical and cosmeceutical industries, our Boswellia Extract is the definitive ingredient for formulating advanced joint health supplements, mobility support products, and topical anti-inflammatory solutions.

Authenticity begins at the source. Our Boswellia Serrata resin is ethically and sustainably harvested from wildcrafted trees in the dry, mountainous regions of Rajasthan and Madhya Pradesh, India, the native habitat where the boswellic acid profile is most potent. We work directly with certified local cooperatives that employ "tapping" methods-making precise incisions in the bark to collect the oleo-gum-resin without harming the tree, ensuring long-term sustainability and forest preservation.

Chain of Custody & Traceability: Every batch is linked to its geographical origin. Our sourcing partners are certified for Good Agricultural and Collection Practices (GACP) as per WHO guidelines, guaranteeing raw material integrity, absence of adulterants, and compliance with international biodiversity and fair-trade principles (Convention on Biological Diversity - Nagoya Protocol).

The therapeutic power of our extract lies in its precise and consistent chemical profile. We standardize for the full spectrum of beneficial boswellic acids, with a focus on key markers.

Primary Bioactive Constituents:

* 3-O-Acetyl-11-keto-β-Boswellic Acid (AKBA): ≥ 65%. The most potent anti-inflammatory component, a direct and selective inhibitor of 5-LOX.

* 11-Keto-β-Boswellic Acid (KBA): ≥ 5%.

* Total Boswellic Acids (β-Boswellic Acid, Acetyl-β-Boswellic Acid, etc.): ≥ 90%.

*Other Bioactives: Contains essential oils (monoterpenes, diterpenes) and polysaccharides which may contribute to synergistic effects.

Physical Properties:

* Appearance: Fine, free-flowing powder ranging from light beige to pale brown.

* Odor & Taste: Characteristic aromatic, slightly bitter taste typical of pure boswellia.

* Solubility: Soluble in ethanol, methanol, and DMSO; insoluble in water. Ideal for encapsulation, tabletting, and liposomal/emulsion delivery systems.

Our commitment to quality is quantified. Each batch is validated against stringent specifications with a comprehensive, lot-specific COA.

TABLE: Boswellia Serrata Extract Powder - Full Specifications

Our state-of-the-art, cGMP-certified extraction process is designed to preserve the delicate boswellic acid profile while ensuring purity and potency.

1.Raw Material Authentication & Preparation: Incoming Boswellia resin is authenticated via macroscopic, microscopic, and TLC/HPLC methods. It is then cleaned and mechanically milled into a coarse powder.

2.Selective Supercritical CO₂ Extraction (Primary): We employ supercritical CO₂ (SFE) technology as a clean, solvent-free initial step. This critical phase removes the volatile essential oil fraction under low temperature and pressure, preserving the thermolabile boswellic acids from degradation.

3.Bioactive Enrichment & Standardization: The de-oiled resin undergoes a proprietary, multi-stage ethanol-water extraction and chromatographic enrichment process. This step selectively isolates and concentrates the boswellic acid fraction, targeting the critical AKBA and KBA components to achieve the precise 65%/90% standardization.

4.Purification & Filtration: The extract solution undergoes nanofiltration and low-temperature vacuum concentration to remove unwanted plant materials, fats, and waxes.

5.Spray Drying: The purified concentrate is converted into a stable, free-flowing powder using low-temperature spray drying with organic rice maltodextrin as a carrier, ensuring optimal solubility and blendability.

6.QC, Standardization & Packaging: The final powder is homogenized and rigorously tested. It is then packaged in food-grade, foil-laminate bags with oxygen scavengers to prevent oxidation and ensure stability.

* Unmatched Potency: 65% AKBA, 90% Total Boswellic Acids-the industry's highest, most clinically relevant standardization for guaranteed efficacy.

* Superior Extraction Technology: Utilization of supercritical CO₂ and selective chromatography ensures a clean, solvent-residue-free, and highly bioavailable extract.

* Full Traceability & Sustainability: Ethically wildcrafted with full GACP compliance and transparent supply chain documentation.

* Enhanced Bioavailability Profile: Our proprietary processing method yields a extract with optimized particle size and chemical profile for improved gastrointestinal absorption.

* Comprehensive Regulatory Support: We provide a full technical dossier, including stability data, safety profiles (GRAS considerations), and documentation to support FDA, EFSA, and other regional regulatory filings.

The efficacy of our high-AKBA Boswellia Extract is supported by a robust body of pharmacological and clinical research.

* Primary Mechanism: Selective 5-LOX Inhibition: AKBA potently and selectively inhibits the 5-lipoxygenase (5-LOX) enzyme, thereby reducing the synthesis of pro-inflammatory leukotrienes (LTB4) without affecting the gastro-protective prostaglandins synthesized via the COX-1 pathway (*Ammon H.P., 2016 - Planta Medica*). This mechanism underlines its excellent safety profile.

* Joint Health & Mobility Support: Multiple randomized, double-blind, placebo-controlled trials demonstrate that Boswellia extract significantly improves pain scores, joint stiffness, and physical function in subjects with osteoarthritis, with efficacy comparable to some conventional agents but with superior tolerability (*Majeed et al., 2019 - Journal of Medicinal Food*).

* Support for Healthy Inflammatory Response: Modulates key inflammatory mediators (TNF-α, IL-1β, IL-6) and inhibits matrix metalloproteinases (MMPs) that degrade cartilage, providing comprehensive support for connective tissue health.

* Respiratory & Gut Health: Emerging research supports its role in promoting a healthy respiratory tract and gut lining by modulating inflammatory pathways specific to these tissues.

Our Boswellia Extract Powder is engineered for seamless integration into a wide array of consumer health products:

* Joint & Mobility Supplements: The flagship application. Formulated into tablets, capsules (veg & gel), and softgels, often combined with glucosamine, chondroitin, MSM, turmeric (curcumin), and hyaluronic acid for synergistic joint support.

* Targeted Topical Formulations: Incorporated into creams, gels, balms, and transdermal patches for localized joint and muscle comfort, leveraging its anti-inflammatory properties.

* Sports Nutrition & Recovery: Added to post-workout recovery powders, protein blends, and functional beverages to support exercise-induced inflammatory response and muscle recovery.

* General Wellness & Healthy Aging: Used in comprehensive wellness formulas targeting systemic inflammatory balance and long-term mobility.

* Veterinary Nutraceuticals: An increasingly popular ingredient in companion animal supplements for senior pet joint care.

● R&D team of 40 members to provide full technical support.
● Years of successful experience with top food companies in the world.
● Dedicate on build long-term relationships with our clients and developing deeps partnership.

* Standard Packaging: 1 kg aluminum foil bag (with polyethylene inner layer), vacuum-sealed and nitrogen-flushed. Outer packaging: 10 kg or 25 kg fiber drum.

* Custom Packaging: Available upon request (e.g., 5 kg bags, 20 kg boxes).

* Storage Conditions: Store in a cool, dry place (below 25°C/77°F) in tightly sealed original containers. Protect from light, moisture, and oxygen.

* Shelf Life: 24 months from the production date when stored under recommended conditions.

* Global Logistics: We expertly manage global shipping via EXW, FOB, CIF, DAP. All necessary documentation-including Certificate of Analysis, Certificate of Origin, MSDS (Safety Data Sheet), Phytosanitary Certificate, and Commercial Invoice-is provided for hassle-free customs clearance worldwide.

Q1: Why is a 65% AKBA extract superior to a standard 10-20% Boswellia extract?
A1: Potency and Clinical Relevance. AKBA is the most active single compound for 5-LOX inhibition. A 65% AKBA extract delivers a therapeutically effective dose in a smaller capsule/tablet, enhancing consumer compliance and product differentiation. Most high-quality clinical trials use extracts standardized to high AKBA content (40-70%).

Q2: Is your Boswellia Extract "all-natural" despite the high standardization?
A2: Yes. Our 65% AKBA is achieved through physical and chromatographic enrichment processes (no chemical modification or synthetic addition) that concentrate the natural boswellic acids already present in the resin. The carrier (organic rice maltodextrin) is also natural. We provide chromatograms proving the natural fingerprint.

Q3: Do you have data on the bioavailability of your extract?
A3: While boswellic acids inherently have low oral bioavailability due to poor solubility, our proprietary extraction and spray-drying process creates an amorphous powder with increased surface area, which enhances dissolution. We recommend formulating with bioavailability enhancers (piperine, phospholipids, or specific lipid-based delivery systems) and can provide guidance on effective combinations.

Q4: Can you support a Novel Food application in the European Union?
A4: Boswellia serrata extracts have a history of safe use. For novel applications (e.g., extracts with AKBA > specified limits in certain food categories), we provide the full chemical characterization, manufacturing details, and toxicological data from our suppliers to form the basis of your Novel Food dossier for EFSA submission.

Q5: What is the recommended daily dosage for formulation?
A5: Clinical studies typically use 100-250 mg of a high-AKBA extract (like ours) per day, often split into 2-3 doses. For a product with a single daily serving of 1-2 capsules, a common formulation is 150-200 mg of our 65% AKBA extract per capsule, providing 97.5-130 mg of AKBA daily. Our technical team can help you design an optimal dosage form.

Q6：How can we contact you?
A：You can click the inquiry on Boswellia extract powder or send us an e-mail to contact@joywinworld.com.

Hot Tags: boswellia extract powder, manufacturers, suppliers, factory, wholesale, buy, price, bulk, high quality, for sale, free sample, Boswellia Serrata Powder Boswellic Acids 65 , Hops Humulus Lupulus Extract Powder, Aloin Aloe Vera Extract Powder, Antibiotic Echinacea Extract Powder, Grapefruit Peel Extract 98 Naringin , Pine Bark Extract Powder